viernes, 5 de abril de 2019

Drug Safety and Availability > FDA updates on angiotensin II receptor blocker (ARB) recalls including valsartan, losartan and irbesartan

Drug Safety and Availability > FDA updates on angiotensin II receptor blocker (ARB) recalls including valsartan, losartan and irbesartan



FDA updates on angiotensin II receptor blocker (ARB) recalls including valsartan, losartan and irbesartan

Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)